deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02091167

Bilateral Prefrontal Modulation in Crack-cocaine Addiction (tDCS_CRACK)

Prefrontal Modulation by Repetitive Bilateral Transcranial Direct Current Stimulation (tDCS) in Crack-cocaine Addicted Inpatients.

Sponsor: Conselho Nacional de Desenvolvimento Científico e Tecnológico

Updated 9 times since 2017 Last updated: Mar 29, 2019 Started: Nov 30, 2013 Primary completion: Jul 31, 2018 Completion: Jul 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02091167, this PHASE2 trial focuses on Drug Addiction and Executive Dysfunction and remains completed. Sponsored by Conselho Nacional de Desenvolvimento Científico e Tecnológico, it has been updated 9 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotRecruiting~Jun 2018 – ~Jul 2019 · 13 months · monthly snapshotRecruiting~Jul 2019 – ~Jan 2021 · 18 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshotCompleted~Jan 2022 – ~Jul 2024 · 30 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2022 — Jul 2024 [monthly]

    Completed PHASE2

  4. Dec 2021 — Jan 2022 [monthly]

    Completed PHASE2

  5. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE2

Show 4 earlier versions
  1. Jul 2019 — Jan 2021 [monthly]

    Completed PHASE2

    Status: RecruitingCompleted

  2. Jun 2018 — Jul 2019 [monthly]

    Recruiting PHASE2

  3. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  4. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Federal University of Espirito Santo
  • Harvard Medical School (HMS and HSDM)
  • University of Göttingen
Data source: Federal University of Espirito Santo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations